Delivery Order SPE2DB20D2002-SPE2DB23FL18U
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,068.18 firm-fixed-price contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a performance period through August 7, 2024. This contract is not set-aside for any small business program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX Eye Ointment 3.5GM. The $3,547.88 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will deliver these medical supplies to support federal healthcare providers and programs. This delivery order is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, with a ceiling value of $1,454.21 and a performance period ending on June 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,323.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. This is a delivery order contract with a firm-fixed price pricing type, with an ultimate completion date of November 6, 2023. The contract does not have a set-aside designation, indicating open...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a ceiling value of $1,622.97 and a performance period through July 2, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide TOBRADEX eye ointment. The $1,777.39 contract has a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX eye ointment. The order is valued at $6,353.15 and has a firm fixed price. The contract has an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY6HS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.51 firm fixed-price delivery order is for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL18UDelivery Order
This is a $2,545.89 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, with a completion date of February 13, 2023. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 2/10/23 |